ACE-536

· Acceleron Pharma, Inc. (a subsidiary of Merck & Co.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACE-536, covering 2012-11-07 to 2012-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of ACE-536 in Healthy Postmenopausal Women [Phase 1]